Starburst amacrine cells, involved in visual motion perception, lose their synaptic input from dopaminergic amacrine cells and degenerate in Parkinson’s disease patients

Background The main clinical symptoms characteristic of Parkinson’s disease (PD) are bradykinesia, tremor, and other motor deficits. However, non-motor symptoms, such as visual disturbances, can be identified at early stages of the disease. One of these symptoms is the impairment of visual motion pe...

Full description

Saved in:
Bibliographic Details
Published inTranslational neurodegeneration Vol. 12; no. 1; pp. 1 - 16
Main Authors Sánchez-Sáez, Xavier, Ortuño-Lizarán, Isabel, Sánchez-Castillo, Carla, Lax, Pedro, Cuenca, Nicolás
Format Journal Article
LanguageEnglish
Published London BioMed Central 03.04.2023
BMC
Subjects
Online AccessGet full text
ISSN2047-9158
2047-9158
DOI10.1186/s40035-023-00348-y

Cover

Abstract Background The main clinical symptoms characteristic of Parkinson’s disease (PD) are bradykinesia, tremor, and other motor deficits. However, non-motor symptoms, such as visual disturbances, can be identified at early stages of the disease. One of these symptoms is the impairment of visual motion perception. Hence, we sought to determine if the starburst amacrine cells, which are the main cellular type involved in motion direction selectivity, are degenerated in PD and if the dopaminergic system is related to this degeneration. Methods Human eyes from control ( n  = 10) and PD ( n  = 9) donors were available for this study. Using immunohistochemistry and confocal microscopy, we quantified starburst amacrine cell density (choline acetyltransferase [ChAT]-positive cells) and the relationship between these cells and dopaminergic amacrine cells (tyrosine hydroxylase-positive cells and vesicular monoamine transporter-2-positive presynapses) in cross-sections and wholemount retinas. Results First, we found two different ChAT amacrine populations in the human retina that presented different ChAT immunoreactivity intensity and different expression of calcium-binding proteins. Both populations are affected in PD and their density is reduced compared to controls. Also, we report, for the first time, synaptic contacts between dopaminergic amacrine cells and ChAT-positive cells in the human retina. We found that, in PD retinas, there is a reduction of the dopaminergic synaptic contacts into ChAT cells. Conclusions Taken together, this work indicates degeneration of starburst amacrine cells in PD related to dopaminergic degeneration and that dopaminergic amacrine cells could modulate the function of starburst amacrine cells. Since motion perception circuitries are affected in PD, their assessment using visual tests could provide new insights into the diagnosis of PD.
AbstractList Abstract Background The main clinical symptoms characteristic of Parkinson’s disease (PD) are bradykinesia, tremor, and other motor deficits. However, non-motor symptoms, such as visual disturbances, can be identified at early stages of the disease. One of these symptoms is the impairment of visual motion perception. Hence, we sought to determine if the starburst amacrine cells, which are the main cellular type involved in motion direction selectivity, are degenerated in PD and if the dopaminergic system is related to this degeneration. Methods Human eyes from control (n = 10) and PD (n = 9) donors were available for this study. Using immunohistochemistry and confocal microscopy, we quantified starburst amacrine cell density (choline acetyltransferase [ChAT]-positive cells) and the relationship between these cells and dopaminergic amacrine cells (tyrosine hydroxylase-positive cells and vesicular monoamine transporter-2-positive presynapses) in cross-sections and wholemount retinas. Results First, we found two different ChAT amacrine populations in the human retina that presented different ChAT immunoreactivity intensity and different expression of calcium-binding proteins. Both populations are affected in PD and their density is reduced compared to controls. Also, we report, for the first time, synaptic contacts between dopaminergic amacrine cells and ChAT-positive cells in the human retina. We found that, in PD retinas, there is a reduction of the dopaminergic synaptic contacts into ChAT cells. Conclusions Taken together, this work indicates degeneration of starburst amacrine cells in PD related to dopaminergic degeneration and that dopaminergic amacrine cells could modulate the function of starburst amacrine cells. Since motion perception circuitries are affected in PD, their assessment using visual tests could provide new insights into the diagnosis of PD.
Background The main clinical symptoms characteristic of Parkinson’s disease (PD) are bradykinesia, tremor, and other motor deficits. However, non-motor symptoms, such as visual disturbances, can be identified at early stages of the disease. One of these symptoms is the impairment of visual motion perception. Hence, we sought to determine if the starburst amacrine cells, which are the main cellular type involved in motion direction selectivity, are degenerated in PD and if the dopaminergic system is related to this degeneration. Methods Human eyes from control ( n  = 10) and PD ( n  = 9) donors were available for this study. Using immunohistochemistry and confocal microscopy, we quantified starburst amacrine cell density (choline acetyltransferase [ChAT]-positive cells) and the relationship between these cells and dopaminergic amacrine cells (tyrosine hydroxylase-positive cells and vesicular monoamine transporter-2-positive presynapses) in cross-sections and wholemount retinas. Results First, we found two different ChAT amacrine populations in the human retina that presented different ChAT immunoreactivity intensity and different expression of calcium-binding proteins. Both populations are affected in PD and their density is reduced compared to controls. Also, we report, for the first time, synaptic contacts between dopaminergic amacrine cells and ChAT-positive cells in the human retina. We found that, in PD retinas, there is a reduction of the dopaminergic synaptic contacts into ChAT cells. Conclusions Taken together, this work indicates degeneration of starburst amacrine cells in PD related to dopaminergic degeneration and that dopaminergic amacrine cells could modulate the function of starburst amacrine cells. Since motion perception circuitries are affected in PD, their assessment using visual tests could provide new insights into the diagnosis of PD.
ArticleNumber 17
Author Lax, Pedro
Cuenca, Nicolás
Sánchez-Sáez, Xavier
Ortuño-Lizarán, Isabel
Sánchez-Castillo, Carla
Author_xml – sequence: 1
  givenname: Xavier
  surname: Sánchez-Sáez
  fullname: Sánchez-Sáez, Xavier
  organization: Department of Physiology, Genetics and Microbiology, University of Alicante
– sequence: 2
  givenname: Isabel
  surname: Ortuño-Lizarán
  fullname: Ortuño-Lizarán, Isabel
  organization: Department of Physiology, Genetics and Microbiology, University of Alicante
– sequence: 3
  givenname: Carla
  surname: Sánchez-Castillo
  fullname: Sánchez-Castillo, Carla
  organization: Department of Physiology, Genetics and Microbiology, University of Alicante
– sequence: 4
  givenname: Pedro
  surname: Lax
  fullname: Lax, Pedro
  organization: Department of Physiology, Genetics and Microbiology, University of Alicante, Alicante Institute for Health and Biomedical Research (ISABIAL)
– sequence: 5
  givenname: Nicolás
  orcidid: 0000-0002-6767-5710
  surname: Cuenca
  fullname: Cuenca, Nicolás
  email: cuenca@ua.es
  organization: Department of Physiology, Genetics and Microbiology, University of Alicante, Alicante Institute for Health and Biomedical Research (ISABIAL), Ramón Margalef Institute, University of Alicante
BookMark eNp9UUtuFDEUtFCQCCEXYOUDpMHd_nTPEkV8IkUCKbC2nu3Xg4duu2V7Ruod1-AM3IqT4MkgRFjEG5fKqiq56jk5CzEgIS9b9qptB_U6C8a4bFjHmwrE0KxPyHnHRN9sWjmc_YOfkcucd6wexaRS8pz8vCuQzD7lQmEGm3xAanGa8hX14RCnA7oK6MHnPUx0jsXHQBdMFpcjvKJTzEjLV_SJ5jVAZW0VLPtCxxRn6uICczVN28o_TKAQHHW4xfoKBY8xnyB98yHH8Ov7j0ydzwjVfYHiMZT8gjwdYcp4-ee-IF_evf18_aG5_fj-5vrNbWM7odZmQCMdU64beiWMkFwyMJY5boZRyZb3YA2qzTg4KUQnrJCtHDeudjR2ahTIL8jNyddF2Okl-RnSqiN4fU_EtNWQ6j8n1Iz1XI3G9MYIIazadBZFbwdmuVEORPXqTl42xZwTjn_9WqaP6-nTerqup-_X02sVDf-JrC9w7Lsk8NPjUn6S5poTtpj0Lu5TqHU9pvoNw-G3Xg
CitedBy_id crossref_primary_10_1212_WNL_0000000000207780
crossref_primary_10_1002_glia_24612
crossref_primary_10_3389_fphar_2023_1288894
crossref_primary_10_1186_s40035_023_00360_2
crossref_primary_10_1007_s00429_024_02799_z
crossref_primary_10_31083_j_fbl2909337
Cites_doi 10.1016/S0006-8993(02)04049-0
10.1126/science.155.3764.841
10.1016/j.ajo.2013.09.028
10.1007/s00401-018-01956-z
10.1097/00006324-199404000-00002
10.1017/S0952523819000087
10.1111/jnc.13144
10.1002/mds.22868
10.1016/j.neuropsychologia.2015.11.019
10.1016/j.tins.2005.06.002
10.1002/ana.24182
10.1016/0042-6989(92)90063-O
10.1093/brain/118.3.771
10.1016/S0042-6989(97)00402-1
10.1002/cne.903100210
10.1523/JNEUROSCI.1784-18.2018
10.1136/jnnp.47.7.673
10.1016/j.devcel.2022.02.018
10.1093/brain/awp068
10.1146/annurev-neuro-072116-031335
10.1016/j.preteyeres.2020.100844
10.1002/cne.902850104
10.1212/WNL.0000000000006157
10.1093/brain/110.6.1675
10.1002/cne.903210106
10.1038/nature06739
10.1038/s41467-022-30405-5
10.1038/nature00931
10.1016/j.tins.2011.08.002
10.1016/j.cell.2021.04.048
10.1093/braincomms/fcab109
10.1016/j.jchemneu.2016.11.003
10.1038/nature22818
10.1371/journal.pone.0054667
10.1038/nrn3165
10.1016/j.parkreldis.2022.06.018
10.1016/j.preteyeres.2020.100938
10.1111/neup.12189
10.1038/s41598-020-66497-6
10.1002/ana.25897
10.1523/JNEUROSCI.07-12-04115.1987
10.1002/mds.27392
10.1001/archophthalmol.2009.106
10.1523/JNEUROSCI.5436-03.2004
10.1186/s40478-018-0596-z
10.1038/s41598-019-48388-7
10.1002/cne.20761
10.1002/mds.21586
10.1038/s41582-022-00618-9
10.1212/01.wnl.0000191565.11065.11
10.1016/0168-5597(95)00169-7
10.1371/journal.pone.0074439
10.1016/j.nbd.2011.06.009
10.1016/j.parkreldis.2019.04.023
10.1016/S1474-4422(06)70600-7
10.3233/JPD-191830
10.1016/S0896-6273(01)00316-6
10.1002/mds.870070308
ContentType Journal Article
Copyright The Author(s) 2023 corrected publication 2023
Copyright_xml – notice: The Author(s) 2023 corrected publication 2023
DBID C6C
AAYXX
CITATION
DOA
DOI 10.1186/s40035-023-00348-y
DatabaseName Springer Nature OA Free Journals
CrossRef
Directory of Open Access Journals
DatabaseTitle CrossRef
DatabaseTitleList

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2047-9158
EndPage 16
ExternalDocumentID oai_doaj_org_article_00736fbb7bb444c692ce47c80c3b6da4
10_1186_s40035_023_00348_y
GrantInformation_xml – fundername: Ministerio de Ciencia e Innovación
  grantid: FEDER-PID 2019-106230RB-I00; FEDER-PID 2019-106230RB-I00
  funderid: http://dx.doi.org/10.13039/501100004837
– fundername: Ministerio de Universidades
  grantid: FPU16/04114
– fundername: Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana
  grantid: IDIFEDER/2017/064; PROMETEO/2021/024; PROMETEO/2021/024; APOSTD/2020/245
  funderid: http://dx.doi.org/10.13039/501100016386
– fundername: Michael J. Fox Foundation for Parkinson's Research
  funderid: http://dx.doi.org/10.13039/100000864
– fundername: FARPE-FUNDALUCE
– fundername: Instituto de Salud Carlos III
  grantid: RETICS-FEDER RD16/0008/0016
  funderid: http://dx.doi.org/10.13039/501100004587
– fundername: Es Retina Asturias
  grantid: 2019/00286/001; 2019/00286/001
GroupedDBID 0R~
5VS
7X7
8FI
8FJ
AAJSJ
AASML
ABUWG
ACGFS
ACIHN
ACMJI
ADBBV
ADRAZ
ADUKV
AEAQA
AFKRA
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
EBLON
EBS
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
IHW
INH
INR
ITC
KQ8
LGEZI
LOTEE
M48
NADUK
NXXTH
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PUEGO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
UKHRP
AAYXX
ALIPV
CITATION
ID FETCH-LOGICAL-c246y-8eb5d06d28764b45350abc0d3b8f65137acbe69f8d54424c4515f9d047f26f4e3
IEDL.DBID M48
ISSN 2047-9158
IngestDate Wed Aug 27 01:22:25 EDT 2025
Tue Jul 01 03:25:29 EDT 2025
Thu Apr 24 22:53:35 EDT 2025
Sat Sep 06 07:18:57 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords ChAT amacrine cells
Human retina
Retinal neurodegeneration
Dopaminergic amacrine cells
Parkinson’s disease
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c246y-8eb5d06d28764b45350abc0d3b8f65137acbe69f8d54424c4515f9d047f26f4e3
ORCID 0000-0002-6767-5710
OpenAccessLink https://doi.org/10.1186/s40035-023-00348-y
PageCount 16
ParticipantIDs doaj_primary_oai_doaj_org_article_00736fbb7bb444c692ce47c80c3b6da4
crossref_primary_10_1186_s40035_023_00348_y
crossref_citationtrail_10_1186_s40035_023_00348_y
springer_journals_10_1186_s40035_023_00348_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20230403
PublicationDateYYYYMMDD 2023-04-03
PublicationDate_xml – month: 4
  year: 2023
  text: 20230403
  day: 3
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Translational neurodegeneration
PublicationTitleAbbrev Transl Neurodegener
PublicationYear 2023
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References NK Archibald (348_CR1) 2009; 132
KR Chaudhuri (348_CR2) 2010; 25
TG Beach (348_CR30) 2015; 35
U Grunert (348_CR33) 2020; 78
E Marrocco (348_CR44) 2020; 10
P Martinez-Martin (348_CR3) 2007; 22
D Regan (348_CR5) 1984; 47
EY Uc (348_CR10) 2005; 65
G Debertin (348_CR40) 2015; 134
E Garcia-Martin (348_CR58) 2014; 157
CA Wang (348_CR11) 2016; 80
MS Sung (348_CR61) 2019; 9
R Netser (348_CR12) 2021; 11
RW Rodieck (348_CR26) 1989; 285
H Kolb (348_CR39) 1991; 310
OS Dhande (348_CR51) 2019; 39
RD Jones (348_CR4) 1992; 7
I Ortuño-Lizarán (348_CR15) 2020; 88
A Chrysou (348_CR60) 2019; 64
RA Cliburn (348_CR34) 2017; 83–84
J Ahn (348_CR59) 2018; 91
Y Hao (348_CR32) 2021; 184
AS Mauss (348_CR19) 2017; 40
I Ortuño-Lizarán (348_CR17) 2018; 33
L Campello (348_CR41) 2013; 8
S Sabbah (348_CR50) 2017; 546
I Bodis-Wollner (348_CR6) 1987; 110
348_CR28
348_CR29
DI Vaney (348_CR54) 2012; 13
T Euler (348_CR20) 2002; 418
P Witkovsky (348_CR35) 2004; 24
CW Oyster (348_CR48) 1979; 155
S Moritoh (348_CR53) 2013; 8
AH Kashani (348_CR14) 2021; 83
ED Thomas (348_CR31) 2021; 57
I Bodis-Wollner (348_CR18) 2014; 75
RH Masland (348_CR23) 2005; 28
N Cuenca (348_CR22) 2003; 964
P Calabresi (348_CR36) 2006; 5
N Cuenca (348_CR42) 2005; 493
T Voigt (348_CR38) 1987; 7
ME Hajee (348_CR57) 2009; 127
BA Haug (348_CR8) 1995; 118
BC Regan (348_CR7) 1998; 38
W Wei (348_CR46) 2011; 34
K Yoshida (348_CR21) 2001; 30
RW Rodieck (348_CR25) 1992; 321
NI Bohnen (348_CR37) 2021; 3
YJ Kim (348_CR52) 2022; 13
JY Lee (348_CR56) 2022; 18
J Esteve-Rudd (348_CR43) 2011; 44
348_CR47
GL Trick (348_CR9) 1994; 71
L Veys (348_CR45) 2019; 137
IJ Kim (348_CR49) 2008; 452
I Ortuño-Lizarán (348_CR16) 2018; 6
AJ Chandra (348_CR24) 2019; 36
LGM Mello (348_CR55) 2022; 101
GD Guiloff (348_CR27) 1992; 32
M Tagliati (348_CR13) 1996; 100
References_xml – volume: 964
  start-page: 21
  issue: 1
  year: 2003
  ident: 348_CR22
  publication-title: Brain Res
  doi: 10.1016/S0006-8993(02)04049-0
– ident: 348_CR47
– volume: 155
  start-page: 841
  issue: 3764
  year: 1979
  ident: 348_CR48
  publication-title: Science
  doi: 10.1126/science.155.3764.841
– volume: 157
  start-page: 470
  issue: 2
  year: 2014
  ident: 348_CR58
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2013.09.028
– ident: 348_CR28
– volume: 137
  start-page: 379
  issue: 3
  year: 2019
  ident: 348_CR45
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-018-01956-z
– volume: 71
  start-page: 242
  issue: 4
  year: 1994
  ident: 348_CR9
  publication-title: Optom Vis Sci
  doi: 10.1097/00006324-199404000-00002
– volume: 36
  start-page: E009
  year: 2019
  ident: 348_CR24
  publication-title: Vis Neurosci
  doi: 10.1017/S0952523819000087
– volume: 134
  start-page: 416
  issue: 3
  year: 2015
  ident: 348_CR40
  publication-title: J Neurochem
  doi: 10.1111/jnc.13144
– volume: 25
  start-page: 704
  issue: 6
  year: 2010
  ident: 348_CR2
  publication-title: Mov Disord
  doi: 10.1002/mds.22868
– volume: 80
  start-page: 176
  year: 2016
  ident: 348_CR11
  publication-title: Neuropsychologia
  doi: 10.1016/j.neuropsychologia.2015.11.019
– volume: 28
  start-page: 395
  issue: 8
  year: 2005
  ident: 348_CR23
  publication-title: Trends Neurosci
  doi: 10.1016/j.tins.2005.06.002
– volume: 75
  start-page: 964
  issue: 6
  year: 2014
  ident: 348_CR18
  publication-title: Ann Neurol
  doi: 10.1002/ana.24182
– volume: 32
  start-page: 2023
  issue: 11
  year: 1992
  ident: 348_CR27
  publication-title: Vision Res
  doi: 10.1016/0042-6989(92)90063-O
– volume: 118
  start-page: 771
  issue: Pt 3
  year: 1995
  ident: 348_CR8
  publication-title: Brain
  doi: 10.1093/brain/118.3.771
– volume: 38
  start-page: 3427
  issue: 21
  year: 1998
  ident: 348_CR7
  publication-title: Vision Res
  doi: 10.1016/S0042-6989(97)00402-1
– volume: 310
  start-page: 267
  issue: 2
  year: 1991
  ident: 348_CR39
  publication-title: J Comp Neurol
  doi: 10.1002/cne.903100210
– volume: 39
  start-page: 78
  issue: 1
  year: 2019
  ident: 348_CR51
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.1784-18.2018
– volume: 47
  start-page: 673
  issue: 7
  year: 1984
  ident: 348_CR5
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.47.7.673
– volume: 57
  start-page: 820
  issue: 6
  year: 2021
  ident: 348_CR31
  publication-title: Dev Cell
  doi: 10.1016/j.devcel.2022.02.018
– volume: 132
  start-page: 1128
  issue: Pt 5
  year: 2009
  ident: 348_CR1
  publication-title: Brain
  doi: 10.1093/brain/awp068
– volume: 40
  start-page: 211
  year: 2017
  ident: 348_CR19
  publication-title: Annu Rev Neurosci
  doi: 10.1146/annurev-neuro-072116-031335
– volume: 78
  start-page: 100844
  year: 2020
  ident: 348_CR33
  publication-title: Prog Retin Eye Res
  doi: 10.1016/j.preteyeres.2020.100844
– volume: 285
  start-page: 18
  issue: 1
  year: 1989
  ident: 348_CR26
  publication-title: J Comp Neurol
  doi: 10.1002/cne.902850104
– volume: 91
  start-page: e1003
  issue: 11
  year: 2018
  ident: 348_CR59
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000006157
– volume: 110
  start-page: 1675
  issue: Pt 6
  year: 1987
  ident: 348_CR6
  publication-title: Brain
  doi: 10.1093/brain/110.6.1675
– volume: 321
  start-page: 46
  issue: 1
  year: 1992
  ident: 348_CR25
  publication-title: J Comp Neurol
  doi: 10.1002/cne.903210106
– volume: 452
  start-page: 478
  issue: 7186
  year: 2008
  ident: 348_CR49
  publication-title: Nature
  doi: 10.1038/nature06739
– volume: 13
  start-page: 2862
  issue: 1
  year: 2022
  ident: 348_CR52
  publication-title: Nat Commun
  doi: 10.1038/s41467-022-30405-5
– volume: 418
  start-page: 845
  issue: 6900
  year: 2002
  ident: 348_CR20
  publication-title: Nature
  doi: 10.1038/nature00931
– volume: 34
  start-page: 638
  issue: 12
  year: 2011
  ident: 348_CR46
  publication-title: Trends Neurosci
  doi: 10.1016/j.tins.2011.08.002
– volume: 184
  start-page: 3573
  issue: 13
  year: 2021
  ident: 348_CR32
  publication-title: Cell
  doi: 10.1016/j.cell.2021.04.048
– volume: 3
  start-page: fcab109
  issue: 2
  year: 2021
  ident: 348_CR37
  publication-title: Brain Commun
  doi: 10.1093/braincomms/fcab109
– volume: 83–84
  start-page: 82
  year: 2017
  ident: 348_CR34
  publication-title: J Chem Neuroanat
  doi: 10.1016/j.jchemneu.2016.11.003
– volume: 546
  start-page: 492
  issue: 7659
  year: 2017
  ident: 348_CR50
  publication-title: Nature
  doi: 10.1038/nature22818
– volume: 8
  start-page: e54667
  issue: 1
  year: 2013
  ident: 348_CR53
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0054667
– volume: 13
  start-page: 194
  issue: 3
  year: 2012
  ident: 348_CR54
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn3165
– volume: 101
  start-page: 90
  year: 2022
  ident: 348_CR55
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/j.parkreldis.2022.06.018
– volume: 83
  start-page: 100938
  year: 2021
  ident: 348_CR14
  publication-title: Prog Retin Eye Res
  doi: 10.1016/j.preteyeres.2020.100938
– volume: 35
  start-page: 354
  issue: 4
  year: 2015
  ident: 348_CR30
  publication-title: Neuropathology
  doi: 10.1111/neup.12189
– volume: 10
  start-page: 9619
  issue: 1
  year: 2020
  ident: 348_CR44
  publication-title: Sci Rep
  doi: 10.1038/s41598-020-66497-6
– volume: 88
  start-page: 893
  issue: 5
  year: 2020
  ident: 348_CR15
  publication-title: Ann Neurol
  doi: 10.1002/ana.25897
– volume: 7
  start-page: 4115
  issue: 12
  year: 1987
  ident: 348_CR38
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.07-12-04115.1987
– volume: 33
  start-page: 1315
  issue: 8
  year: 2018
  ident: 348_CR17
  publication-title: Mov Disord
  doi: 10.1002/mds.27392
– volume: 127
  start-page: 737
  issue: 6
  year: 2009
  ident: 348_CR57
  publication-title: Arch Ophthalmol
  doi: 10.1001/archophthalmol.2009.106
– volume: 24
  start-page: 4242
  issue: 17
  year: 2004
  ident: 348_CR35
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.5436-03.2004
– volume: 6
  start-page: 90
  issue: 1
  year: 2018
  ident: 348_CR16
  publication-title: Acta Neuropathol Commun
  doi: 10.1186/s40478-018-0596-z
– volume: 9
  start-page: 11832
  issue: 1
  year: 2019
  ident: 348_CR61
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-48388-7
– volume: 493
  start-page: 261
  issue: 2
  year: 2005
  ident: 348_CR42
  publication-title: J Comp Neurol
  doi: 10.1002/cne.20761
– volume: 22
  start-page: 1623
  issue: 11
  year: 2007
  ident: 348_CR3
  publication-title: Mov Disord
  doi: 10.1002/mds.21586
– volume: 18
  start-page: 203
  issue: 4
  year: 2022
  ident: 348_CR56
  publication-title: Nat Rev Neurol
  doi: 10.1038/s41582-022-00618-9
– volume: 65
  start-page: 1907
  issue: 12
  year: 2005
  ident: 348_CR10
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000191565.11065.11
– volume: 100
  start-page: 1
  issue: 1
  year: 1996
  ident: 348_CR13
  publication-title: Electroencephalogr Clin Neurophysiol
  doi: 10.1016/0168-5597(95)00169-7
– volume: 8
  start-page: e74439
  issue: 9
  year: 2013
  ident: 348_CR41
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0074439
– ident: 348_CR29
– volume: 44
  start-page: 102
  issue: 1
  year: 2011
  ident: 348_CR43
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2011.06.009
– volume: 64
  start-page: 40
  year: 2019
  ident: 348_CR60
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/j.parkreldis.2019.04.023
– volume: 5
  start-page: 974
  issue: 11
  year: 2006
  ident: 348_CR36
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(06)70600-7
– volume: 11
  start-page: 251
  issue: 1
  year: 2021
  ident: 348_CR12
  publication-title: J Parkinsons Dis
  doi: 10.3233/JPD-191830
– volume: 30
  start-page: 771
  issue: 3
  year: 2001
  ident: 348_CR21
  publication-title: Neuron
  doi: 10.1016/S0896-6273(01)00316-6
– volume: 7
  start-page: 232
  issue: 3
  year: 1992
  ident: 348_CR4
  publication-title: Mov Disord
  doi: 10.1002/mds.870070308
SSID ssj0000605665
Score 2.2638304
Snippet Background The main clinical symptoms characteristic of Parkinson’s disease (PD) are bradykinesia, tremor, and other motor deficits. However, non-motor...
Abstract Background The main clinical symptoms characteristic of Parkinson’s disease (PD) are bradykinesia, tremor, and other motor deficits. However,...
SourceID doaj
crossref
springer
SourceType Open Website
Enrichment Source
Index Database
Publisher
StartPage 1
SubjectTerms Biomedical and Life Sciences
Biomedicine
ChAT amacrine cells
Dopaminergic amacrine cells
Human retina
Neurology
Neurosciences
Parkinson’s disease
Retinal neurodegeneration
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NSiQxEA7iYfEi6x876koO3nYaM92VdPq4K4oIelrBW8jvImg7mB5hbr6Gz-Bb-SRbSfcMyoJe9taEpKupqk5VpVJfEXIIwB3kip5aQgGAAUqjHRS2LEPNeHBlRue_uBRnV3B-za_ftPpKd8J6eOCecUcplSSCMbUxAGBFU1oPtZXMVkY4nZFAWcPeBFP9HoyGXfBFlYwURxEyOiOaqCJhsshi_s4SZcD-f7Kh2cicfiXrg3dIf_ZftUFWfLtJvlwM-e8t8oK-YWJD7Ki-0zZV7tF09B7H9KbFjebRO3ygjzdxhq_pO_TQ6fLuypje3kdPc3KAxnmrcdTigumso6nOhDoMoe9yOSCOv6dAdeuo838yTHXnE5lUMZ2Lx16fniMdUj10QGqN2-Tq9OT38VkxtFtAwYCYF9Ib7phwGEMJMMArzrSxzFVGBsEnVa2t8aIJ0nGUKVhAVyg0jkEdShHAVztktb1v_TdCJw1KRhjuLbMgq4mGqmTWu5BOnAJjIzJZsF7ZAYs8tcS4VTkmkUL14lIoLpXFpeYj8mO5ZtojcXw4-1eS6HJmQtHOA6hbatAt9Zlujch4oQ9q-LXjBzR3_wfNPbJWZiWFglX7ZLV7mPnv6Pd05iCr-F9lvwHY
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dShwxFA7Vgngjba24_SMXvesOZmdOMpnLdqlIwV5V8C7kVwQdFzO7sHe-Rp_Bt_JJPMlml0qL0LshJBMm30lyTs58Xwj5DMAdZEZPK6ECwACl0w4qW9ehZTy4Oqvzn_4UJ2fw45yfF5mcxIX5M38_keIoQhZVxJ2lSlIqslpukZccF95kzVMx3ZynMPTLheBrXsw_mz7Ze7JE_1_5z7ytHL8ie8UfpF9XAL4mL3z_huycloz3PrlHbzB9eByovtY2cfVoOmyPY3rZ49Ky8A4f6OIyzvE1qzt56Gzzt8qYXt1ET3M6gMZlr7HUYoPZfKCJWUIdBs3XmQCI5U97oLp31PmLLEw9-NRN4khnutjD3e9IS3KHFm3W-JacHX__NT2pygULCAWIZSW94Y4Jh1GTAAO84Uwby1xjZBA4yK22xosuSMcRRbCAzk_oHIM21CKAbw7Idn_T-0NCJ53TIAz3llmQzURDUzPrXUhnTIGxEZmsh17Zoj6eLsG4UjkKkUKt4FIIl8pwqeWIfNm0ma20N56t_S0huqmZdLNzAZqTKtNQpcSkCMa0xgCAFV1tPbRWMtsYgV8wIuO1PagymeMzfb77v-rvyW6dzREq1nwg28Pt3H9En2Ywn7IxPwLMPvIw
  priority: 102
  providerName: Springer Nature
Title Starburst amacrine cells, involved in visual motion perception, lose their synaptic input from dopaminergic amacrine cells and degenerate in Parkinson’s disease patients
URI https://link.springer.com/article/10.1186/s40035-023-00348-y
https://doaj.org/article/00736fbb7bb444c692ce47c80c3b6da4
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEBZ5QOmlNH3Q7WPRobeuW9keyfKhlO2SEBbSS7uQm7FeIbDxbtfeUN_6N_ob-q_6SzqS7YWQEMjNCEuyZ0aaGY3mG0LeA3ADIaMnkxABoIOSlwYinSQuY9yZJKDzn30TpwuYn_PzPTKUO-oJWN_p2vl6UovN8uOvn-0XXPCfw4KX4lMNAXgRtU_k4VZk1O6TwxAv8lf5enO_25lR3YfqkokHKMhjLoc8mjuHuaGrAqT_rXhpUEMnT8mT3n6k047hR2TPVs_Io7M-Qv6c_EXr0ROqbmh5VWqf20f94Xw9oZcVbkXX1uADvb6stzhMV8OHrne3WyZ0uaotDeEDWrdVia0aO6y3DfWZKNSgk30VEgax_eYMtKwMNfYiAFk31k_jc6pDetm_339q2geDaI_lWr8gi5PjH7PTqC_IgKwD0UbSKm6YMOhlCVDAU85KpZlJlXSCx2lWamVF7qThyHXQgMaSyw3S2iXCgU1fkoNqVdlXhMa5KUEobjXTINO4hDRh2hrnz6QcYyMSD6QvdI9W7otmLIvgtUhRdOwqkF1FYFfRjsiHXZ91h9Vx79tfPUd3b3qc7dCw2lwU_bItfCBTOKUypQBAizzRFjItmU6VwD8YkckgD8Ugu_fM-fpBX_iGPE6CNELE0rfkoNls7Ts0gRo1JofT6fz7fEz2Z2I2DgcJ4yDr_wHQoAWX
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3LbtQwFLWgSMAG8RTD0wt2TISTXDvOEkZUA3S6aqXuLD9RpTYd4Uyl2fEbfAN_xZdw7fGMqECV2EWWHcs-1_G9vjnHhLwB4A4yo6eTUAFggNJrB5VtmtAxHlyT1fkXh2J-DJ9P-EmRyUlcmD_z97UU7yJkUUXcWaokpSKr9U1yK2Uuk07-TMx25ykM_XIh-JYX88-mV_aeLNH_V_4zbyv798m94g_S9xsAH5AbfnhIbi9KxvsR-YneYBp4HKk-1zZx9Wg6bI9Tejrgp-XSO3ygl6dxha_Z3MlDl7u_Vab07CJ6mtMBNK4HjaUWGyxXI03MEuowaD7PBEAsv9oD1YOjzn_NwtSjT90kjnSmi_36_iPSktyhRZs1PibH-x-PZvOqXLCAUIBYV9Ib7phwGDUJMMBbzrSxzLVGBsHrttPWeNEH6TiiCBbQ-Qm9Y9CFRgTw7ROyN1wM_imhde80CMO9ZRZkW2toG2a9C-mMKTA2IfV26pUt6uPpEowzlaMQKdQGLoVwqQyXWk_I212b5UZ749raHxKiu5pJNzsXoDmpsgxVSkyKYExnDABY0TfWQ2cls60ROIIJmW7tQZXFHK_p89n_VX9N7syPFgfq4NPhl-fkbpNNEyrWviB747eVf4n-zWheZcP-DVgG9R8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3LatwwFBVtAqGb0iedPrXormOisa9keTl9DOm0CYU2kJ3QMwQSzxB7ArPrb_Qb-lf9kl7JmqGhJdCdEZKFdSTrPnSOCHkNwB0kRk8toQBAB6XRDgpblqFmPLgyqfMfHomDY5if8JM_WPzptPsmJTlwGqJKU9vvL10YlrgU-x0kqUXcb4oosCKL9W2yK3nToPu1O53Ov863cRaG9roQfMOX-Wfja3tSku7_Ky-atpvZPXI324l0OgB7n9zy7QOyd5gz4Q_JT7QS44B0PdUX2kYOH41B-G5Mz1r85Vx5hw_06qxb4WuGu3rocnuKZUzPF52nKU1Au3WrsdRig-Wqp5FxQh060xeJGIjl13ugunXU-dMkWN372E3kTica2a_vPzqakz40a7Z2j8jx7MO3dwdFvngBIQKxLqQ33DHh0JsSYIBXnGljmauMDIJPqlpb40UTpOOILlhAoyg0jkEdShHAV4_JTrto_RNCJ43TIAz3llmQ1URDVTLrXYixp8DYiEw2Q69sViWPl2Ocq-SdSKEGuBTCpRJcaj0ib7ZtloMmx42130ZEtzWjnnYqWFyeqrw8VUxYimBMbQwAWNGU1kNtJbOVEfgFIzLezAeVF3l3Q59P_6_6K7L35f1Mff549OkZuVOmmQkFq56Tnf5y5V-g2dObl3lm_wavEf7d
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Starburst+amacrine+cells%2C+involved+in+visual+motion+perception%2C+lose+their+synaptic+input+from+dopaminergic+amacrine+cells+and+degenerate+in+Parkinson%E2%80%99s+disease+patients&rft.jtitle=Translational+neurodegeneration&rft.au=S%C3%A1nchez-S%C3%A1ez%2C+Xavier&rft.au=Ortu%C3%B1o-Lizar%C3%A1n%2C+Isabel&rft.au=S%C3%A1nchez-Castillo%2C+Carla&rft.au=Lax%2C+Pedro&rft.date=2023-04-03&rft.issn=2047-9158&rft.eissn=2047-9158&rft.volume=12&rft.issue=1&rft_id=info:doi/10.1186%2Fs40035-023-00348-y&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s40035_023_00348_y
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2047-9158&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2047-9158&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2047-9158&client=summon